JPH09291021A - Beautifying and whitening cosmetic - Google Patents
Beautifying and whitening cosmeticInfo
- Publication number
- JPH09291021A JPH09291021A JP8131063A JP13106396A JPH09291021A JP H09291021 A JPH09291021 A JP H09291021A JP 8131063 A JP8131063 A JP 8131063A JP 13106396 A JP13106396 A JP 13106396A JP H09291021 A JPH09291021 A JP H09291021A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- vitamin
- derivatives
- derivative
- birch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 25
- 230000002087 whitening effect Effects 0.000 title claims abstract description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 15
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims abstract description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000196324 Embryophyta Species 0.000 claims abstract description 9
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960004705 kojic acid Drugs 0.000 claims abstract description 9
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims abstract description 9
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 8
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 8
- 239000011719 vitamin A Substances 0.000 claims abstract description 8
- 229940045997 vitamin a Drugs 0.000 claims abstract description 8
- 235000020778 linoleic acid Nutrition 0.000 claims abstract description 7
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 7
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 6
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 6
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 6
- 239000011720 vitamin B Substances 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 26
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 12
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 10
- 210000002826 placenta Anatomy 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 8
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 7
- 229960004488 linolenic acid Drugs 0.000 claims description 7
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 5
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 5
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 5
- 229940055726 pantothenic acid Drugs 0.000 claims description 5
- 235000019161 pantothenic acid Nutrition 0.000 claims description 5
- 239000011713 pantothenic acid Substances 0.000 claims description 5
- 206010034972 Photosensitivity reaction Diseases 0.000 claims 2
- 230000036211 photosensitivity Effects 0.000 claims 2
- 235000001553 Betula platyphylla Nutrition 0.000 claims 1
- 241001313086 Betula platyphylla Species 0.000 claims 1
- 241001262617 Japonica Species 0.000 claims 1
- 208000012641 Pigmentation disease Diseases 0.000 abstract description 13
- 230000019612 pigmentation Effects 0.000 abstract description 11
- 238000002156 mixing Methods 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 6
- 235000003932 Betula Nutrition 0.000 abstract description 2
- 241000219429 Betula Species 0.000 abstract description 2
- 208000003351 Melanosis Diseases 0.000 abstract description 2
- 206010042496 Sunburn Diseases 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 229960004232 linoleic acid Drugs 0.000 abstract 2
- 241000219495 Betulaceae Species 0.000 abstract 1
- 230000003169 placental effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 150000003839 salts Chemical class 0.000 description 22
- 150000002148 esters Chemical class 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- -1 acetyl pantothenyl ethyl ether Chemical compound 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 239000003504 photosensitizing agent Substances 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 244000274847 Betula papyrifera Species 0.000 description 3
- 235000009113 Betula papyrifera Nutrition 0.000 description 3
- 235000009109 Betula pendula Nutrition 0.000 description 3
- 235000010928 Betula populifolia Nutrition 0.000 description 3
- 235000002992 Betula pubescens Nutrition 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical class [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 2
- 229940031016 ethyl linoleate Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 1
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 description 1
- SOQQSPURSLWWMI-UHFFFAOYSA-N 1,3-thiazole-4-carbothioamide Chemical compound NC(=S)C1=CSC=N1 SOQQSPURSLWWMI-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 229920000064 Ethyl eicosapentaenoic acid Polymers 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001166994 Kummerowia striata Species 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001237745 Salamis Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DPRNENKPXAZQBI-UHFFFAOYSA-N alpha-Vitamin A Natural products OCC=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C DPRNENKPXAZQBI-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 description 1
- JYYFMIOPGOFNPK-AGRJPVHOSA-N ethyl linolenate Chemical compound CCOC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC JYYFMIOPGOFNPK-AGRJPVHOSA-N 0.000 description 1
- 229940090028 ethyl linolenate Drugs 0.000 description 1
- JYYFMIOPGOFNPK-UHFFFAOYSA-N ethyl linolenate Natural products CCOC(=O)CCCCCCCC=CCC=CCC=CCC JYYFMIOPGOFNPK-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- 229960002600 icosapent ethyl Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 229940040452 linolenate Drugs 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-M linolenate Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC([O-])=O DTOSIQBPPRVQHS-PDBXOOCHSA-M 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 239000004306 orthophenyl phenol Substances 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000015175 salami Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- GQTHJBOWLPZUOI-FJXQXJEOSA-M sodium D-pantothenate Chemical class [Na+].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GQTHJBOWLPZUOI-FJXQXJEOSA-M 0.000 description 1
- 229940068459 sodium pantothenate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- WYPBVHPKMJYUEO-NBTZWHCOSA-M sodium;(9z,12z)-octadeca-9,12-dienoate Chemical compound [Na+].CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O WYPBVHPKMJYUEO-NBTZWHCOSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、日焼け(紫外線)
による皮膚の黒化あるいはシミ、ソバカスなど皮膚の色
素沈着を消失もしくは淡色化し、あるいはこれらを予防
する美白化粧料に関する。TECHNICAL FIELD The present invention relates to a sunburn (ultraviolet ray).
The present invention relates to a whitening cosmetic composition that eliminates or diminishes skin pigmentation due to skin darkening or spots, freckles, and the like, or prevents these.
【0002】[0002]
【従来の技術】従来、美白化粧料組成物としてはビタミ
ンCおよびその誘導体、あるいは還元剤、プラセンタエ
キスなどチロシンからメラニンを生成するチロシナーゼ
の活性阻害剤を配合したものが知られている。例えば、
特開昭61−194008号公報には、L−アスコルビ
ン酸(ビタミンC)およびそのエステルから選ばれた一
種または二種以上と、ヘチマの液汁とを含有する化粧料
について記載されている。また、特開昭57−7761
0号公報には、ウリ科植物のメラニン産生抑制作用につ
いて記載されている。2. Description of the Related Art Conventionally, as a whitening cosmetic composition, there has been known a composition containing vitamin C and its derivative, or a reducing agent, a placenta extract, and an activity inhibitor of tyrosinase which produces melanin from tyrosine. For example,
Japanese Unexamined Patent Publication No. 61-194008 describes a cosmetic containing one or more selected from L-ascorbic acid (vitamin C) and its ester, and loofah juice. Also, JP-A-57-7761
Japanese Unexamined Patent Publication No. 0 describes the melanin production inhibitory action of Cucurbitaceae plants.
【0003】しかしながら、これら従来の美白化粧料は
培養細胞によるin vitroの実験ではメラニン産
生抑制作用などを示すものの、実際の皮膚に適用した場
合、充分な色素沈着の消失もしくは淡色化などの効果は
得られず、また皮膚に対する刺激がある等の副作用があ
った。However, although these conventional whitening cosmetics show a melanin production inhibitory effect in an in vitro experiment using cultured cells, when they are applied to actual skin, they are not effective in eliminating pigmentation or fading. It was not obtained, and there were side effects such as irritation to the skin.
【0004】[0004]
【発明の解決しようとする課題】本発明の目的は、優れ
た美白効果を有し、かつ皮膚に対する刺激のない化粧料
を提供することにある。An object of the present invention is to provide a cosmetic having an excellent whitening effect and not irritating the skin.
【0005】[0005]
【課題を解決するための手段】本発明者らは、優れた美
白化粧料を得るべく鋭意研究を重ねた結果、カバノキ科
カバノキ属に属する植物の樹液にプラセンタエキス、リ
ノール酸、ビタミンAなどの特定成分を加えることによ
り、その美白作用が強化されると共に、皮膚刺激の少な
い化粧料が得られることを知り、本発明を完成するに至
った。カバノキ科カバノキ属に属する植物の樹液は、昔
から民間療法的に欧州、中国、韓国、日本などで、便
秘、扁桃腺炎、咳・喉痛、発熱、リューマチ、火傷炎
症、高血圧、利尿、痛風などに用いらているがその美白
作用については知られていない。Means for Solving the Problems As a result of intensive studies to obtain an excellent whitening cosmetic composition, the present inventors have found that the sap of plants belonging to the genus Birch of the birch family, such as placenta extract, linoleic acid and vitamin A. The present inventors have completed the present invention, knowing that the addition of a specific component enhances the whitening effect and a cosmetic with less skin irritation can be obtained. The sap of plants belonging to the genus Birchaceae has been used as folk remedies in Europe, China, South Korea, Japan, etc. for a long time in constipation, tonsillitis, cough / throat pain, fever, rheumatism, burn inflammation, hypertension, diuresis, gout. It is used for the above, but its whitening effect is not known.
【0006】すなわち、本発明は、カバノキ科カバノキ
属に属する植物の樹液とプラセンタエキス、リノール酸
およびその塩またはエステル、リノレン酸およびその塩
またはエステル、トウキエキス、エイコサペンタン酸お
よびその塩またはエステル、ヘキサドコサエン酸および
その塩またはエステル、パントテン酸およびその塩また
はエステル、ビタミンA、ビタミンB,ビタミンEおよ
びその塩またはエステル、感光素201号、感光素40
1号並びにコウジ酸およびその塩またはエステルより選
ばれた少なくとも1種の成分とを配合したことを特徴と
する美白化粧料を提供するものである。That is, the present invention relates to sap and a placenta extract of a plant belonging to the genus Birch of the family Birchaceae, linoleic acid and its salts or esters, linolenic acid and its salts or esters, touki extract, eicosapentaenoic acid and its salts or esters. , Hexadocosaenoic acid and its salt or ester, pantothenic acid and its salt or ester, vitamin A, vitamin B, vitamin E and its salt or ester, Photosensitizer No. 201, Photosensitizer 40
No. 1 and at least one component selected from kojic acid and a salt or ester thereof are provided to provide a whitening cosmetic composition.
【0007】[0007]
【発明の実施の形態】本発明で用いるカバノキ科カバノ
キ属に属する植物の樹液としては、シラカンバ、ダケカ
ンバ、ヤエガワカンバ、ヤチカンバなどのカバノキ科カ
バノキ属に属する植物から得られ、特にシラカンバ(
Betula platyphylla var. j
aponica )が好ましい。これら樹液は、その幹
に小さな穴を穿けることによって採取することができ、
その時期は早春が好適である。この溢出される樹液は9
9.3%が水分であり、残部が固形分量である。糖成分
としてグルコース、フラクトース、ミネラル成分として
カリウム、ナトリウム、カルシウム、マグネシウム、マ
ンガン、鉄、亜鉛などを含み、その他アミノ酸や有機
酸、蛋白質などを含有している。BEST MODE FOR CARRYING OUT THE INVENTION The sap of a plant belonging to the genus Birch of the family Birchaceae used in the present invention is obtained from a plant belonging to the genus Birch of the family Birchaceae, such as birch, moss birch, Jaechava birch and Yachi bimba, and in particular birch (
Betula ptyphylla var. j
aponica) is preferred. These sap can be collected by making a small hole in the trunk,
Early spring is suitable at that time. This overflowing sap is 9
9.3% is water and the rest is solid content. It contains glucose, fructose as a sugar component, potassium, sodium, calcium, magnesium, manganese, iron, zinc and the like as a mineral component, and also contains other amino acids, organic acids, proteins and the like.
【0008】本発明の化粧料中におけるシラカンバ樹液
の配合量は、化粧料全量中の3〜99重量%、好ましく
は、5〜95重量%、さらに好ましくは5〜90重量%
である。シラカンバ樹液の配合量が3%未満であると皮
膚の色素沈着の消失、もしくは淡色化の効果が低く、一
方99%を超えると防腐剤、安定剤、保存剤の配合が制
限され、シラカンバ樹液の保存安定性が低下し好ましく
ない。The amount of birch sap in the cosmetic of the present invention is 3 to 99% by weight, preferably 5 to 95% by weight, more preferably 5 to 90% by weight, based on the total amount of the cosmetic.
It is. If the content of birch sap is less than 3%, the skin pigmentation disappears or the effect of lightening is low, while if it exceeds 99%, the composition of preservatives, stabilizers and preservatives is restricted, and It is not preferable because the storage stability is lowered.
【0009】採取したシラカンバ樹液はそのまま放置す
ると、腐敗、菌の繁殖などが生ずる。このため採取した
シラカンバ樹液にエタノール、パラオキシ安息香酸エス
テルまたはその塩、安息香酸またはその塩、サリチル酸
またはその塩、ソルビン酸またはその塩、デヒドロ酢酸
またはその塩、イソプロピルメチルフェノール、オルト
フェニルフェノール、クレゾール、フェノキシエタノー
ルなどの防腐剤を適宜添加することが望ましい。[0009] If the collected birch sap is left as it is, spoilage, propagation of bacteria and the like occur. Therefore, ethanol, paraoxybenzoic acid ester or a salt thereof, benzoic acid or a salt thereof, salicylic acid or a salt thereof, sorbic acid or a salt thereof, dehydroacetic acid or a salt thereof, isopropylmethylphenol, orthophenylphenol, cresol, is collected in white birch sap. It is desirable to appropriately add a preservative such as phenoxyethanol.
【0010】本発明化粧料においてシラカンバ樹液と共
に配合される成分としては、プラセンタエキス、リノー
ル酸およびその塩またはエステル、リノレン酸およびそ
の塩またはエステル、トウキエキス、エイコサペンタン
酸およびその塩またはエステル、ヘキサドコサエン酸お
よびその塩またはエステル、パントテン酸およびその塩
またはエステル、ビタミンA、ビタミンB,ビタミンE
およびその誘導体、感光素201号、感光素401号並
びにコウジ酸およびその塩またはエステルなどが挙げら
れる。これらは単独でまた併用して配合されてよい。Ingredients to be blended with the birch sap in the cosmetic composition of the present invention include placenta extract, linoleic acid and salts or esters thereof, linolenic acid and salts or esters thereof, touki extract, eicosapentaenoic acid and salts or esters thereof, Hexadocosaenoic acid and its salts or esters, Pantothenic acid and its salts and esters, Vitamin A, Vitamin B, Vitamin E
And its derivatives, Photosensitizer No. 201, Photosensitizer No. 401, and kojic acid and its salts or esters. These may be blended alone or in combination.
【0011】リノール酸の誘導体としては、リノール酸
カリウム、リノール酸ナトリウムなどの塩、およびリノ
ール酸メチル、リノール酸エチル、リノール酸イソプロ
ピルなどのエステルが挙げられる。リノレン酸として
は、α−リノレン酸、γ−リノレン酸が挙げられ、その
誘導体としてはα−リノレン酸ナトリウムなどの塩、γ
−リノレン酸エチルなどのエステルが挙げられる。Examples of the derivative of linoleic acid include salts such as potassium linoleate and sodium linoleate, and esters such as methyl linoleate, ethyl linoleate and isopropyl linoleate. Examples of linolenic acid include α-linolenic acid and γ-linolenic acid, and derivatives thereof include salts such as α-sodium linolenate and γ.
-Esters such as ethyl linolenate.
【0012】パントテン酸の誘導体としてはパントテン
酸カルシウム、パントテン酸ナトリウムなどの塩、パン
トテニルエチルエーテル、アセチルパントテニルエチル
エーテルなどが挙げられる。ビタミンA(レチノール)
の誘導体としては、酢酸レチノール、パルミチン酸レチ
ノールなどのエステル、およびデヒドロレチノールなど
が挙げられる。ビタミンE(dl−α−トコフェロー
ル)の誘導体としては、酢酸dl−α−トコフェロー
ル、リノール酸dl−α−トコフェロール、リノレン酸
dl−α−トコフェロールなどのエステルが挙げられ
る。また、コウジ酸の誘導体としては、コウジ酸ナトリ
ウムなどの塩、コウジ酸エチルなどのエステルが挙げら
れる。Examples of the derivative of pantothenic acid include salts of calcium pantothenate, sodium pantothenate and the like, pantothenyl ethyl ether, acetyl pantothenyl ethyl ether and the like. Vitamin A (retinol)
Examples of the derivatives include an ester such as retinol acetate and retinol palmitate, and dehydroretinol. Derivatives of vitamin E (dl-α-tocopherol) include esters such as dl-α-tocopherol acetate, dl-α-tocopherol linoleate, and dl-α-tocopherol linolenate. Examples of the kojic acid derivative include salts such as sodium kojic acid and esters such as ethyl kojic acid.
【0013】これら成分の配合量は、各成分に応じて適
宜調整される。プラセンタエキス、リノール酸、リノレ
ン酸、エイコサペンタン酸、ヘキサドコサエン酸および
その誘導体は、いずれも化粧料全量に対して0.05〜
50重量%、好ましくは0.1〜10重量%配合する。
トウキエキス、コウジ酸およびその誘導体は、いずれも
0.05〜10重量%、好ましくは0.1〜5重量%配
合する。また、パントテン酸およびその誘導体は、0.
001〜10重量%、好ましくは0.01〜10重量%
配合する。ビタミンA、ビタミンB,ビタミンEは、
0.01〜10重量%、好ましくは0.1〜5重量%配
合する。感光素201号、感光素401号は、0.00
01〜0.5重量%、好ましくは0.001〜0.1重
量%配合する。The blending amounts of these components are appropriately adjusted according to each component. Placenta extract, linoleic acid, linolenic acid, eicosapentaenoic acid, hexadocosaenoic acid and their derivatives are all 0.05 to 0.05% based on the total amount of the cosmetic.
50% by weight, preferably 0.1 to 10% by weight is blended.
Touki extract, kojic acid and its derivatives are added in an amount of 0.05 to 10% by weight, preferably 0.1 to 5% by weight. In addition, pantothenic acid and its derivatives are 0.
001 to 10% by weight, preferably 0.01 to 10% by weight
Mix. Vitamin A, vitamin B, and vitamin E are
The amount is 0.01 to 10% by weight, preferably 0.1 to 5% by weight. Photosensitive element 201 and photosensitive element 401 are 0.00
The amount is 01 to 0.5% by weight, preferably 0.001 to 0.1% by weight.
【0014】本発明の美白化粧料は、公知の方法により
クリーム、乳液、化粧水、パック、ファンデーション、
エッセンスなどの化粧料としてに調製される。また、本
発明の化粧料には、その種類に応じ性能を損なわない範
囲において、適宜公知の成分を配合することができる。
すなわち、本発明の化粧料には上記必須成分の他に、通
常化粧料に用いられ配合される成分、例えば、油分、紫
外線吸収剤、酸化防止剤、界面活性剤、防腐剤、香料、
水、アルコール、増粘剤、色素等を必要に応じて適宜配
合することができる。The whitening cosmetic composition of the present invention comprises creams, emulsions, lotions, packs, foundations, and
It is prepared as cosmetics such as essence. Further, the cosmetics of the present invention may be appropriately blended with known components within a range that does not impair the performance depending on the type.
That is, the cosmetic of the present invention, in addition to the above essential components, components usually used and blended in cosmetics, for example, oils, ultraviolet absorbers, antioxidants, surfactants, preservatives, fragrances,
Water, alcohol, a thickener, a dye, and the like can be appropriately added as needed.
【0015】[0015]
【実施例】次に、本発明を実施例により、より詳しく説
明する。言うまでもなく、本願発明はこれら実施例に限
られることはない。また、特に断らないかぎり、[%]
は重量%を表す。表1に示す、実施例(及び比較例)を
常法により、調製し、その色素沈着抑制作用を評価し
た。評価方法を示す。 <試験方法>English系茶色モルモットの背部を
剃毛し、紫外線(UVB強度:1J/cm2)を照射し
た。この操作を3日間繰り返し、その間後記第1表に示
す検体(試験例1〜24)を紫外線照射部に塗布した。
10日間放置後、以下に示す判定基準に従い、色素沈着
度を肉眼判定した。 (判定基準) − :色素沈着なし ± :わずかな色素沈着 + :中等度の色素沈着 ++:強度の色素沈着Next, the present invention will be described in more detail with reference to examples. Needless to say, the present invention is not limited to these examples. Unless otherwise specified, [%]
Represents weight%. The examples (and comparative examples) shown in Table 1 were prepared by a conventional method, and their pigmentation-inhibiting action was evaluated. The evaluation method will be described. <Test Method> The back of an English brown guinea pig was shaved and irradiated with ultraviolet rays (UVB intensity: 1 J / cm2). This operation was repeated for 3 days, during which the specimens (Test Examples 1 to 24) shown in Table 1 below were applied to the ultraviolet irradiation part.
After being left for 10 days, the degree of pigmentation was visually evaluated according to the following criteria. (Criteria) −: No pigmentation ±: Slight pigmentation +: Moderate pigmentation ++: Intense pigmentation
【0016】[0016]
【表1】 [Table 1]
【0017】[0017]
【表2】 [Table 2]
【0018】表1、表2に示す結果から、実施例は比較
例に比べて、色素沈着の顕著な淡色化が認められた。 実施例12(クリーム) 成 分 配合量(%) モノステアリン酸ソルビタン 2.0 自己乳化型モノステアリン酸グリセリン 3.0 ミリスチン酸セチル 1.5 ミリスチン酸イソプロピル 3.0 セタノール 2.0 ステアリン酸 2.0 流動パラフィン 7.0 トリエタノールアミン 0.4 パラオキシ安息香酸メチル 0.2 パラオキシ安息香酸ブチル 0.1 1,3−ブチレングリコール 6.0 シラカンバ樹液 50.0 エタノール 2.0 プラセンタエキス 5.0 トウキエキス 1.0 香料 0.2 精製水 残部 計 100.0From the results shown in Tables 1 and 2, it was confirmed that the Examples were markedly lighter in pigmentation than the Comparative Examples. Example 12 (Cream) Component Blending amount (%) Sorbitan monostearate 2.0 Self-emulsifying glyceryl monostearate 3.0 Cetyl myristate 1.5 Isopropyl myristate 3.0 Cetanol 2.0 Stearic acid 2. 0 liquid paraffin 7.0 triethanolamine 0.4 methyl paraoxybenzoate 0.2 butyl paraoxybenzoate 0.1 1,3-butylene glycol 6.0 birch sap 50.0 ethanol 2.0 placenta extract 5.0 Toki Extract 1.0 Perfume 0.2 Purified water Balance 100.0
【0019】 実施例13(乳液) 成 分 配合量(%) 自己乳化型モノステアリン酸グリセリン 3.0 ステアリン酸 1.5 セタノール 1.0 流動パラフィン 5.0 パルミチン酸イソプロピル 2.0 トリエタノールアミン 0.3 ポリオキシエチレンモノステアリン酸 ソルビタン(20E.O.) 1.0 パラオキシ安息香酸エチル 0.3 プロピレングリコール 5.0 シラカンバ樹液 70.0 カルボキシビニルポリマー 0.3 リノール酸 3.0 感光素401号 0.002 香料 0.15 精製水 残部 計 100.0Example 13 (Emulsion) Component Blending amount (%) Self-emulsifying glyceryl monostearate 3.0 Stearic acid 1.5 Cetanol 1.0 Liquid paraffin 5.0 Isopropyl palmitate 2.0 Triethanolamine 0 .3 Polyoxyethylene monostearate sorbitan (20EO) 1.0 Ethyl paraoxybenzoate 0.3 Propylene glycol 5.0 Birch sap 70.0 Carboxyvinyl polymer 0.3 Linoleic acid 3.0 Photosensitizer No. 401 0.002 Perfume 0.15 Purified water Balance 100.0
【0020】 実施例14(化粧水) 成 分 配合量(%) ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.7 エタノール 12.0 香料 0.1 感光素201号 0.002 1,3−ブチレングリコール 5.0 クエン酸 0.2 クエン酸ナトリウム 0.3 dl−ピロリドンカルボン酸ナトリウム 1.0 シラカンバ樹液 70.0 プラセンタエキス 5.0 精製水 残部 計 100.0Example 14 (Toilet lotion) Component Blending amount (%) Polyoxyethylene hydrogenated castor oil (40 EO) 0.7 Ethanol 12.0 Perfume 0.1 Photosensitizer No. 201 0.002 1,3 -Butylene glycol 5.0 Citric acid 0.2 Sodium citrate 0.3 dl-Pyrrolidonecarboxylate sodium 1.0 Birch sap 70.0 Placenta extract 5.0 Purified water balance 100.0
【0021】 実施例15(パック) 成 分 配合量(%) ポリビニルアルコール 15.0 エタノール 14.0 プロピレングリコール 4.0 ポリオキシエチレン(20E.O.)セチルエーテル 0.6 香料 0.15 シラカンバ樹液 50.0 コウジ酸 0.5 酸化チタン 5.0 タルク 2.0 リノール酸エチル 1.0 精製水 残部 計 100.0Example 15 (pack) Component Blending amount (%) Polyvinyl alcohol 15.0 Ethanol 14.0 Propylene glycol 4.0 Polyoxyethylene (20EO) cetyl ether 0.6 Perfume 0.15 White birch sap 50.0 Kojic acid 0.5 Titanium oxide 5.0 Talc 2.0 Ethyl linoleate 1.0 Purified water Residual total 100.0
【0022】 実施16(化粧用エッセンス) 成 分 配合量(%) エイコサペンタエン酸エチル 1.0 グリセリン 15.0 エタノール 8.0 ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.9 パラオキシ安息香酸エチル 0.1 シラカンバ樹液 65.0 香料 0.1 カルボキシビニルポリマー 0.6 トリエタノールアミン 0.3 精製水 残部 計 100.0Example 16 (Cosmetic Essence) Component Blending amount (%) Ethyl eicosapentaenoate 1.0 Glycerin 15.0 Ethanol 8.0 Polyoxyethylene hydrogenated castor oil (60EO) 0.9 Paraoxybenzoic acid Ethyl 0.1 White birch sap 65.0 Fragrance 0.1 Carboxyvinyl polymer 0.6 Triethanolamine 0.3 Purified water Balance 100.0
【0023】 実施17(パウダー) 成 分 配合量(%) ヘキサドコサエン酸 2.0 デキストリン 90.0 タルク 2.0 ステアリン酸デカグリセリル 1.0 シラカンバ樹液 5.0 計 100.0Example 17 (Powder) Component Content (%) Hexadocosaenoic acid 2.0 Dextrin 90.0 Talc 2.0 Decaglyceryl stearate 1.0 Birch birch sap 5.0 Total 100.0
【0024】 実施例18(パック) 成 分 配合量(%) パントテン酸カルシウム 2.0 シラカンバ樹液 45.0 酢酸ビニル・スチレン共重合体 10.0 ポリビニルアルコール 10.0 ソルビット 5.0 酸化チタン 6.0 カオリン 5.0 エタノール 8.0 香料 0.2 パラオキシ安息香酸メチル 0.1 精製水 残部 計 100.0Example 18 (pack) Component Blending amount (%) Calcium pantothenate 2.0 Shira birch sap 45.0 Vinyl acetate / styrene copolymer 10.0 Polyvinyl alcohol 10.0 Sorbit 5.0 Titanium oxide 6. 0 Kaolin 5.0 Ethanol 8.0 Fragrance 0.2 Methyl paraoxybenzoate 0.1 Purified water Balance 100.0
【0025】 実施例19(乳液) 成 分 配合量(%) 酢酸レチノール 0.02 シラカンバ樹液 70.0 流動パラフィン 5.0 ワセリン 2.0 ミツロウ 2.0 セスキオレイン酸ソルビタン 2.0 ポリオキシエチレンオレイルエーテル(20E.O.) 2.5 パラオキシ安息香酸エチル 0.3 プロピレングリコール 5.0 カルボキシビニルポリマー 0.5 水酸化カリウム 0.3 香料 0.1 精製水 残部 計 100.0Example 19 (Emulsion) Component Content (%) Retinol acetate 0.02 Birch sap 70.0 Liquid paraffin 5.0 Vaseline 2.0 Beeswax 2.0 Sorbitan sesquioleate 2.0 Polyoxyethylene oleyl Ether (20 EO) 2.5 Ethyl paraoxybenzoate 0.3 Propylene glycol 5.0 Carboxyvinyl polymer 0.5 Potassium hydroxide 0.3 Perfume 0.1 Purified water balance 100.0 in total
【0026】 実施例20(クリーム) 成 分 配合量(%) リノール酸トコフェロール 1.0 サラシミツロウ 4.0 セタノール 2.0 ステアリン酸 2.0 ミリスチン酸イソプロピル 5.0 ラノリン 2.0 流動パラフィン 6.0 自己乳化型モノステアリン酸グリセリル 3.0 モノステアリン酸ポリオキシエチレン ソルビタン(20E.O.) 2.0 パラオキシ安息香酸プロピル 0.1 パラオキシ安息香酸メチル 0.3 プロピレングリコール 5.0 シラカンバ樹液 50.0 香料 0.2 精製水 残部 計 100.0Example 20 (Cream) Component Blending amount (%) Tocopherol linoleate 1.0 Salami beeswax 4.0 Cetanol 2.0 Stearic acid 2.0 Isopropyl myristate 5.0 Lanolin 2.0 Liquid paraffin 6. 0 Self-emulsifying type glyceryl monostearate 3.0 Polyoxyethylene sorbitan monostearate (20 EO) 2.0 Propyl paraoxybenzoate 0.1 Methyl paraoxybenzoate 0.3 Propylene glycol 5.0 Birch sap 50. 0 Perfume 0.2 Purified water Balance 100.0
【0027】 実施例21(化粧水) 成 分 配合量(%) 塩酸ピリドキシン 0.1 グリセリン 4.0 エタノール 10.0 ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.5 パラオキシ安息香酸メチル 0.05 クエン酸 0.05 クエン酸ナトリウム 0.07 シラカンバ樹液 50.0 dl−ピロリドンカルボン酸ナトリウム 1.0 精製水 残部 計 100.0 実施例12〜21の化粧料は、いずれも優れた美白効果
を有していた。Example 21 (Toilet lotion) Component Blending amount (%) Pyridoxine hydrochloride 0.1 Glycerin 4.0 Ethanol 10.0 Polyoxyethylene hydrogenated castor oil (40 EO) 0.5 Methyl paraoxybenzoate 0 .05 citric acid 0.05 sodium citrate 0.07 birch sap 50.0 dl-sodium pyrrolidonecarboxylate 1.0 purified water balance 100.0 The cosmetics of Examples 12 to 21 all have excellent whitening effects. Had.
【0028】[0028]
【発明の効果】本発明のカバノキ科カバノキ属に属する
植物の樹液とプラセンタエキス、リノール酸およびその
誘導体、リノレン酸およびその誘導体、トウキエキス、
エイコサペンタン酸およびその誘導体、ヘキサドコサエ
ン酸およびその誘導体、パントテン酸およびその誘導
体、ビタミンA、ビタミンB、ビタミンEおよびその誘
導体、感光素201号、感光素401号並びにコウジ酸
およびその誘導体などを含有する美白化粧料は、優れた
色素沈着抑制作用を有すると認められた。EFFECTS OF THE INVENTION Sap and placenta extract of plants belonging to the genus Birch of the family Birchaceae of the present invention, linoleic acid and its derivatives, linolenic acid and its derivatives, Japanese clover extract,
Eicosapentaenoic acid and its derivatives, Hexadocosaenoic acid and its derivatives, Pantothenic acid and its derivatives, Vitamin A, Vitamin B, Vitamin E and its derivatives, Photosensitive No. 201, Photosensitive No. 401 and Kojic acid and its derivatives, etc. It was recognized that the whitening cosmetic composition containing the above-mentioned compound has an excellent pigmentation suppressing effect.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/00 A61K 7/00 H ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display area A61K 7/00 A61K 7/00 H
Claims (2)
液、及びプラセンタエキス、リノール酸およびその誘導
体、リノレン酸およびその誘導体、トウキエキス、エイ
コサペンタン酸およびその誘導体、ヘキサドコサエン酸
およびその誘導体、パントテン酸およびその誘導体、ビ
タミンA、ビタミンB、ビタミンEおよびその誘導体、
感光素201号、感光素401号並びにコウジ酸および
その誘導体から選ばれた少なくとも1種以上を配合した
ことを特徴とする美白化粧料。1. A sap of a plant belonging to the genus Birch of the family Birchaceae, placenta extract, linoleic acid and its derivatives, linolenic acid and its derivatives, touki extract, eicosapentaenoic acid and its derivatives, hexadocosaenoic acid and its derivatives, Pantothenic acid and its derivatives, vitamin A, vitamin B, vitamin E and its derivatives,
A whitening cosmetic composition containing at least one selected from Photosensitivity No. 201, Photosensitivity No. 401, and kojic acid and its derivatives.
( Betulaplatyphylla var.
japonica )である請求項1記載の美白化粧
料。2. A plant belonging to the genus Birch is a birch (Betulaplatyphylla var.
The whitening cosmetic composition according to claim 1, which is Japonica).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8131063A JPH09291021A (en) | 1996-04-25 | 1996-04-25 | Beautifying and whitening cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8131063A JPH09291021A (en) | 1996-04-25 | 1996-04-25 | Beautifying and whitening cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH09291021A true JPH09291021A (en) | 1997-11-11 |
Family
ID=15049146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8131063A Pending JPH09291021A (en) | 1996-04-25 | 1996-04-25 | Beautifying and whitening cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH09291021A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6423325B1 (en) * | 1999-07-30 | 2002-07-23 | Conopco, Inc. | Skin care composition |
| US6444647B1 (en) | 1999-04-19 | 2002-09-03 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
| FR2829695A1 (en) * | 2001-09-14 | 2003-03-21 | Sederma Sa | Cosmetic and dermatological compositions, useful for care of the skin, mucosa and attachments, i.e. nails, body or head hair, comprise birch sap |
| JP2004217629A (en) * | 2002-12-26 | 2004-08-05 | Kanebo Ltd | Bleaching agent and vitamin-mixed composition |
| WO2006068254A1 (en) * | 2004-12-24 | 2006-06-29 | Suntory Limited | Skin-whitening agent |
| JP2007320921A (en) * | 2006-06-01 | 2007-12-13 | Nitta Gelatin Inc | Cosmetic comprising sap formulated therein |
| US7808924B2 (en) | 2002-05-24 | 2010-10-05 | Cisco Technology, Inc. | Apparatus and method for preventing disruption of fibre channel fabrics caused by ReConfigure Fabric (RCF) messages |
| KR101278071B1 (en) * | 2010-01-08 | 2013-06-24 | (주)아모레퍼시픽 | Cosmetic composition containing Betula costata extract |
-
1996
- 1996-04-25 JP JP8131063A patent/JPH09291021A/en active Pending
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6444647B1 (en) | 1999-04-19 | 2002-09-03 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
| US6423325B1 (en) * | 1999-07-30 | 2002-07-23 | Conopco, Inc. | Skin care composition |
| FR2829695A1 (en) * | 2001-09-14 | 2003-03-21 | Sederma Sa | Cosmetic and dermatological compositions, useful for care of the skin, mucosa and attachments, i.e. nails, body or head hair, comprise birch sap |
| WO2003024418A3 (en) * | 2001-09-14 | 2003-11-27 | Sederma Sa | Use of birch sap in cosmetic and dermopharmaceutical compositions |
| US7821969B2 (en) | 2002-05-24 | 2010-10-26 | Cisco Technology, Inc. | Apparatus and method for preventing disruption of fibre channel fabrics caused by reconfigure fabric (RCF) messages |
| US7808924B2 (en) | 2002-05-24 | 2010-10-05 | Cisco Technology, Inc. | Apparatus and method for preventing disruption of fibre channel fabrics caused by ReConfigure Fabric (RCF) messages |
| JP2004217629A (en) * | 2002-12-26 | 2004-08-05 | Kanebo Ltd | Bleaching agent and vitamin-mixed composition |
| WO2006068254A1 (en) * | 2004-12-24 | 2006-06-29 | Suntory Limited | Skin-whitening agent |
| JPWO2006068254A1 (en) * | 2004-12-24 | 2008-06-12 | サントリー株式会社 | Whitening agent |
| CN101102744B (en) | 2004-12-24 | 2010-11-03 | 三得利控股株式会社 | Skin-whitening agent |
| JP2012116847A (en) * | 2004-12-24 | 2012-06-21 | Suntory Holdings Ltd | Skin-whitening agent |
| JP5095221B2 (en) * | 2004-12-24 | 2012-12-12 | サントリーホールディングス株式会社 | Whitening agent |
| JP2007320921A (en) * | 2006-06-01 | 2007-12-13 | Nitta Gelatin Inc | Cosmetic comprising sap formulated therein |
| KR101278071B1 (en) * | 2010-01-08 | 2013-06-24 | (주)아모레퍼시픽 | Cosmetic composition containing Betula costata extract |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940000671B1 (en) | Compositions for topical use having melanin synthesis-inhibiting activity | |
| JP2614474B2 (en) | Whitening cosmetics | |
| JPS60202806A (en) | Whitening cosmetic | |
| JPH05186324A (en) | Beautifying cosmetic | |
| JPH01186809A (en) | Skin beautifying cosmetic | |
| KR100882089B1 (en) | Cosmetic composition and method comprising the honggyeongcheon | |
| JP2881333B2 (en) | Whitening cosmetics | |
| DE19720339A1 (en) | Treatment or prevention of undesired skin pigmentation | |
| JP2001122733A (en) | Catalase production-promoting preparation and skin preparation for external use containing the same | |
| JPH08337510A (en) | Melanin production inhibitor | |
| JP2552298B2 (en) | Beautiful skin cosmetics | |
| JPH09291012A (en) | Antiphlogistic skin cosmetic | |
| JPH05201847A (en) | Skin-beautifying cosmetic | |
| JP3432033B2 (en) | Photoaging agent and skin cosmetic containing the same | |
| JP4076477B2 (en) | Skin preparation | |
| JP3170024B2 (en) | Whitening cosmetics | |
| JP2002234828A (en) | Skin whitening cosmetic preparation | |
| JP2006022090A (en) | Inflammation inhibitor comprising pyrrolidone carboxylic acid zinc salt | |
| JPH09175988A (en) | Photoaging agent and skin external preparation | |
| KR101156970B1 (en) | Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same | |
| KR20000076534A (en) | Composition for topical application to the skin and/or its superficial body growths, comprising at least one compound comprising a phenyloxime ftagment | |
| JPH049325A (en) | Beautifying and whitening cosmetic | |
| JP3382146B2 (en) | External preparation for skin | |
| JPH1180016A (en) | Preparation for external use for skin for prevention of aging | |
| JPH03236323A (en) | Skin drug for external use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040414 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040427 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040625 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20041214 |